Global Ophthalmic Anti-VEGF Therapeutics Market By Drug Type (Ranibizumab, Aflibercept, Bevacizumab, Brolucizumab, Faricimab, Others) By Indication (Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Diabetic Retinopathy, Myopic Choroidal Neovascularization, Others) By End User (Hospitals, Ophthalmic Clinics, Ambulatory Surgical Centers, Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035
Report Overview Global Ophthalmic Anti-VEGF Therapeutics Market size is expected to be worth around US$ 29.0 Billion by 2035 from US$ 17.6 Billion in 2025, growing at a CAGR of 5.1% ...